Automating HPLC and GC Analytical Method Validation

Lukulay,Patrick;Verseput,Richard;

Automating HPLC and GC Analytical Method Validation

May 2, 2005

By Patrick Lukulay
Richard Verseput

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-05-02-2005

Volume 29

Issue 5

A newly developed software program transforms written SOPs for all required analytical method validation experiments into transferable automated templates, integrating individual activities and technologies under one platform.

External Link - article-160390.pdf

Articles in this issue

Scalable Membrane Ion-Exchange Chromatography Purification of an Antisense Oligonucleotide

New Vaccine Technologies Carry and Deliver by Kaylynn Chiarello

GenerationNext

New Vaccine Technologies Carry and Deliver

High Molecular Weight Polyethylene Oxide-Based Drug Delivery Systems - Part I: Hydrogels and Hydrophilic Matrix Systems

May 2005

Bar Coding Deadline Looms

In the Spotlight - May 2005

New FDA Policies Shape Pharma Development and Production

Automating HPLC and GC Analytical Method Validation

Price Matters

Related Content

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol

November 21st 2024

Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Feliza Mirasol

November 20th 2024

Article

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol

November 16th 2024

Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.